Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy.

Autor: Saini, Kamal S., Lanza, Carlo, Romano, Marco, de Azambuja, Evandro, Cortes, Javier, de las Heras, Begoña, de Castro, Javier, Lamba Saini, Monika, Loibl, Sibylle, Curigliano, Giuseppe, Twelves, Chris, Leone, Manuela, Patnaik, Mrinal M.
Zdroj: British Journal of Cancer; Sep2020, Vol. 123 Issue 5, p694-697, 4p
Abstrakt: Three cardinal manifestations of neoplasia, namely inflammation, immune dysfunction, and coagulopathy are also seen in patients with severe SARS-CoV-2 infection, providing a biological rationale for testing selected anticancer drugs for their ability to control the symptoms and/or modify the course of COVID-19. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index